MX2009013421A - Mamiferos transgenicos que producen proteinas exogenas en su leche. - Google Patents
Mamiferos transgenicos que producen proteinas exogenas en su leche.Info
- Publication number
- MX2009013421A MX2009013421A MX2009013421A MX2009013421A MX2009013421A MX 2009013421 A MX2009013421 A MX 2009013421A MX 2009013421 A MX2009013421 A MX 2009013421A MX 2009013421 A MX2009013421 A MX 2009013421A MX 2009013421 A MX2009013421 A MX 2009013421A
- Authority
- MX
- Mexico
- Prior art keywords
- human insulin
- transgenic
- mammal
- milk
- recombinant human
- Prior art date
Links
- 241000124008 Mammalia Species 0.000 title abstract 8
- 230000009261 transgenic effect Effects 0.000 title abstract 7
- 235000013336 milk Nutrition 0.000 title abstract 3
- 239000008267 milk Substances 0.000 title abstract 3
- 210000004080 milk Anatomy 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 abstract 7
- 101000976075 Homo sapiens Insulin Proteins 0.000 abstract 4
- 241000283690 Bos taurus Species 0.000 abstract 3
- 239000002243 precursor Substances 0.000 abstract 3
- 235000018102 proteins Nutrition 0.000 abstract 2
- 231100000331 toxic Toxicity 0.000 abstract 2
- 230000002588 toxic effect Effects 0.000 abstract 2
- 102000011632 Caseins Human genes 0.000 abstract 1
- 108010076119 Caseins Proteins 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 229960000074 biopharmaceutical Drugs 0.000 abstract 1
- 238000010367 cloning Methods 0.000 abstract 1
- 210000002257 embryonic structure Anatomy 0.000 abstract 1
- 239000013613 expression plasmid Substances 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 230000001605 fetal effect Effects 0.000 abstract 1
- 210000002950 fibroblast Anatomy 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 210000005075 mammary gland Anatomy 0.000 abstract 1
- 210000000287 oocyte Anatomy 0.000 abstract 1
- 210000001082 somatic cell Anatomy 0.000 abstract 1
- 235000021247 β-casein Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
- C12N15/877—Techniques for producing new mammalian cloned embryos
- C12N15/8771—Bovine embryos
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/101—Bovine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Developmental Biology & Embryology (AREA)
- Animal Husbandry (AREA)
- Animal Behavior & Ethology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invención se refiere a un mamífero transgénico no humano que es útil para la producción de una proteína de interés que puede ser tóxica para el mamífero. El mamífero se caracteriza por el hecho de que es transgénico para la producción en su leche, de una forma inactiva de la proteína de interés, de preferencia insulina humana recombinante. No es posible producir insulina humana recombinante en mamíferos transgénicos ya que esta molécula tiene un cierto grado de actividad biológica en los mamíferos y puede ser tóxica al mamífero. De esta manera, la invención involucra donar una construcción genética que comprende una secuencia que codifica un precursor de insulina humana modificado bajo el control de un promotor beta caseína en un vector de expresión. También involucra transfectar el plásmido de expresión en células somáticas bovinas fetales, tales como fibroblastos, y enuclear oocitos bovinos por transferencia nuclear, para generar embriones transgénicos. La invención da lugar a un bovino transgéníco que será capaz de producir en sus glándulas mamarias un precursor de insulina humana modificado. Posteriormente, la leche de estos mamíferos transgénicos puede recolectarse, el precursor de insulina humana modificado puede convertirse in vitro en insulina humana recombinante y la insulina humana recombinante puede ser.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92909507P | 2007-06-13 | 2007-06-13 | |
| US92909807P | 2007-06-13 | 2007-06-13 | |
| PCT/US2008/007398 WO2008156668A1 (en) | 2007-06-13 | 2008-06-13 | Transgenic mammals that produce exogenous proteins in milk |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009013421A true MX2009013421A (es) | 2010-03-22 |
Family
ID=40156522
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009013421A MX2009013421A (es) | 2007-06-13 | 2008-06-13 | Mamiferos transgenicos que producen proteinas exogenas en su leche. |
| MX2009013371A MX2009013371A (es) | 2007-06-13 | 2008-06-13 | Proceso para producir proteina exogena en la leche de mamiferos transgenicos. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009013371A MX2009013371A (es) | 2007-06-13 | 2008-06-13 | Proceso para producir proteina exogena en la leche de mamiferos transgenicos. |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20090187999A1 (es) |
| EP (2) | EP2061895A1 (es) |
| JP (2) | JP2010528678A (es) |
| CN (2) | CN101802210A (es) |
| AU (2) | AU2008266993A1 (es) |
| BR (1) | BRPI0811390A2 (es) |
| CA (2) | CA2690564A1 (es) |
| CO (2) | CO6300796A2 (es) |
| MX (2) | MX2009013421A (es) |
| RU (2) | RU2010100911A (es) |
| WO (2) | WO2008156668A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20120044358A (ko) * | 2009-07-09 | 2012-05-07 | 바이오콘 리미티드 | 비-선형 구배에 기초한 분취용 크로마토그래피 방법 및 이 방법에 의해 정제된 산물 |
| CN102816819B (zh) * | 2012-08-13 | 2014-10-29 | 山东阿华生物药业有限公司 | 提高人胰岛素前体融合蛋白酶切转换成b30缺苏氨酸人胰岛素产率的方法 |
| AR094778A1 (es) | 2013-02-13 | 2015-08-26 | Laboratoire Français Du Fractionnement Et Des Biotechnologies | Proteínas con glicosilación modificada y métodos para producirlas |
| CA2900909A1 (en) | 2013-02-13 | 2014-08-21 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Highly galactosylated anti-tnf-.alpha. antibodies and uses thereof |
| WO2016080399A1 (ja) | 2014-11-20 | 2016-05-26 | 国立大学法人京都大学 | 哺乳動物の標的ゲノム領域にｄｎａをノックインする方法及び細胞 |
| CN105219774B (zh) * | 2015-10-10 | 2019-04-30 | 广西大学 | 猪胰岛素特异性表达启动子pip2及其应用 |
| CN117327681A (zh) * | 2022-12-31 | 2024-01-02 | 义翘神州(泰州)科技有限公司 | 促进哺乳动物细胞表达蛋白正确折叠的分子伴侣质粒及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4654324A (en) * | 1981-08-27 | 1987-03-31 | Eli Lilly And Company | Human proinsulin pharmaceutical formulations |
| US5322775A (en) * | 1986-06-30 | 1994-06-21 | Pharmaceutical Proteins Ltd. | Peptide production |
| US5633076A (en) * | 1989-12-01 | 1997-05-27 | Pharming Bv | Method of producing a transgenic bovine or transgenic bovine embryo |
| US5831141A (en) * | 1991-01-11 | 1998-11-03 | United States Of America As Represented By The Department Of Health And Human Services | Expression of a heterologous polypeptide in mammary tissue of transgenic non-human mammals using a long whey acidic protein promoter |
| US6011197A (en) * | 1997-03-06 | 2000-01-04 | Infigen, Inc. | Method of cloning bovines using reprogrammed non-embryonic bovine cells |
| CN1058972C (zh) * | 1997-08-15 | 2000-11-29 | 中国农业大学 | 用动物乳房生产人的生长激素 |
| US6451527B1 (en) * | 1997-08-29 | 2002-09-17 | Selective Genetics, Inc. | Methods using genetic package display for selecting internalizing ligands for gene delivery |
| US20030005468A1 (en) * | 1998-06-19 | 2003-01-02 | Meade Harry M. | Methods and vectors for improving nucleic acid expression |
| WO2000000625A1 (en) * | 1998-06-26 | 2000-01-06 | Ppl Therapeutics (Scotland) Limited | Methods for production of recombinant polypeptides |
| CA2382741A1 (en) * | 1999-10-14 | 2001-04-19 | Genzyme Transgenics Corporation | Methods of producing a target molecule in a transgenic animal and purification of the target molecule |
| US7105314B2 (en) * | 2001-04-02 | 2006-09-12 | Novo Nordisk A/S | Method for making human insulin precursors |
| CN1882685A (zh) * | 2003-09-30 | 2006-12-20 | 斯特林贝尔德生物技术北美公司 | 在转基因哺乳动物的奶中生产外源蛋白的方法以及从其中纯化蛋白的方法 |
| AR047720A1 (es) * | 2003-09-30 | 2006-02-15 | Bio Sidus S A | Un proceso para la obtencion de mamiferos transgenicos que produzcan proteinas exogenas en leche y los mamiferos producidos por dicho proceso |
-
2008
- 2008-06-13 CA CA2690564A patent/CA2690564A1/en not_active Abandoned
- 2008-06-13 CA CA2690565A patent/CA2690565A1/en not_active Abandoned
- 2008-06-13 JP JP2010512197A patent/JP2010528678A/ja not_active Withdrawn
- 2008-06-13 AU AU2008266993A patent/AU2008266993A1/en not_active Abandoned
- 2008-06-13 WO PCT/US2008/007398 patent/WO2008156668A1/en active Application Filing
- 2008-06-13 US US12/138,529 patent/US20090187999A1/en not_active Abandoned
- 2008-06-13 JP JP2010512195A patent/JP2010528677A/ja not_active Withdrawn
- 2008-06-13 US US12/138,526 patent/US20090228999A1/en not_active Abandoned
- 2008-06-13 EP EP08768438A patent/EP2061895A1/en not_active Withdrawn
- 2008-06-13 MX MX2009013421A patent/MX2009013421A/es not_active Application Discontinuation
- 2008-06-13 BR BRPI0811390-4A2A patent/BRPI0811390A2/pt not_active IP Right Cessation
- 2008-06-13 MX MX2009013371A patent/MX2009013371A/es not_active Application Discontinuation
- 2008-06-13 CN CN200880022998.8A patent/CN101802210A/zh active Pending
- 2008-06-13 WO PCT/US2008/007400 patent/WO2008156670A1/en active Application Filing
- 2008-06-13 EP EP08768440A patent/EP2061896A1/en not_active Withdrawn
- 2008-06-13 CN CN200880022856A patent/CN101755054A/zh active Pending
- 2008-06-13 RU RU2010100911/10A patent/RU2010100911A/ru unknown
- 2008-06-13 RU RU2010100910/10A patent/RU2010100910A/ru unknown
- 2008-06-13 AU AU2008266995A patent/AU2008266995A1/en not_active Abandoned
-
2010
- 2010-01-13 CO CO10002779A patent/CO6300796A2/es not_active Application Discontinuation
- 2010-01-13 CO CO10002774A patent/CO6300794A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2690564A1 (en) | 2008-12-24 |
| CN101755054A (zh) | 2010-06-23 |
| WO2008156670A1 (en) | 2008-12-24 |
| EP2061895A1 (en) | 2009-05-27 |
| CO6300796A2 (es) | 2011-07-21 |
| MX2009013371A (es) | 2010-01-25 |
| EP2061896A1 (en) | 2009-05-27 |
| CN101802210A (zh) | 2010-08-11 |
| RU2010100910A (ru) | 2011-07-20 |
| AU2008266993A1 (en) | 2008-12-24 |
| WO2008156668A1 (en) | 2008-12-24 |
| AU2008266995A1 (en) | 2008-12-24 |
| RU2010100911A (ru) | 2011-07-20 |
| JP2010528678A (ja) | 2010-08-26 |
| US20090228999A1 (en) | 2009-09-10 |
| BRPI0811390A2 (pt) | 2014-12-30 |
| US20090187999A1 (en) | 2009-07-23 |
| CA2690565A1 (en) | 2008-12-24 |
| CO6300794A2 (es) | 2011-07-21 |
| JP2010528677A (ja) | 2010-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009013421A (es) | Mamiferos transgenicos que producen proteinas exogenas en su leche. | |
| BR112012007854A2 (pt) | metodos de produção de glicoproteínas em culturas de células de mamíferos usando glicocorticoides | |
| WO2005033274A3 (en) | A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom | |
| Zhang et al. | Production of dairy goat embryos, by nuclear transfer, transgenic for human acid β-glucosidase | |
| Feng et al. | Production of transgenic dairy goat expressing human α-lactalbumin by somatic cell nuclear transfer | |
| WO2014097113A3 (en) | Production of therapeutic proteins in genetically modified mammalian cells | |
| Huang et al. | Establishment of a porcine Oct-4 promoter-driven EGFP reporter system for monitoring pluripotency of porcine stem cells | |
| Bai et al. | Generation of a transgenic cashmere goat using the piggyBac transposition system | |
| Zhao et al. | Expression of hIGF-I in the silk glands of transgenic silkworms and in transformed silkworm cells | |
| Niu et al. | Progress in gene transfer by germ cells in mammals | |
| Sato et al. | In vivo genome editing targeted towards the female reproductive system | |
| Wu et al. | P25 gene knockout contributes to human epidermal growth factor production in transgenic silkworms | |
| Singh et al. | Transgenesis and genetically engineered livestock as live bioreactors | |
| Wang et al. | Editing of the heavy chain gene of Bombyx mori using transcription activator like effector nucleases | |
| You et al. | Transgenic silkworms secrete the recombinant glycosylated MRJP1 protein of Chinese honeybee, Apis cerana cerana | |
| AR067333A1 (es) | Un proceso para la produccion de proteinas exogenas en la leche de mamiferos transgenicos y un proceso para purificar proteinas a partir de la misma | |
| Seong et al. | Generation of transgenic silkworms for production of erythropoietin in Bombyx mori | |
| Gui et al. | In vitro evaluation of a mammary gland specific expression vector encoding recombinant human lysozyme for development of transgenic dairy goat embryos | |
| Alfano et al. | Human leukemia inhibitory factor produced by the ExpressTec method from rice (Oryza sativa L.) is active in human neural stem cells and mouse induced pluripotent stem cells | |
| Lisauskas et al. | Expression of functional recombinant human factor IX in milk of mice | |
| Singh et al. | Characterization of GSF289: a fibroblast cell line derived from goat ear skin explants | |
| Song et al. | Developmental analysis of reconstructed embryos of second‐generation cloned transgenic goats | |
| Seong et al. | Analysis of transgenic silkworms producing insulin-like growth factor-I in Bombyx mori | |
| Hasegawa et al. | Pig zona pellucida 2 (pZP2) protein does not participate in zona pellucida formation in transgenic mice | |
| CN103031277B (zh) | 力生长因子在制备无血清培养耐受型哺乳动物工程细胞中的应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |